This review highlights the potential of lipidomic and metabolomic biomarkers in predicting breast cancer prognosis and therapy response, enhancing patient care.
Lipidomics and metabolomics as potential biomarkers for breast cancer progression
- Post author:
- Post published:September 5, 2024
- Post category:uncategorized